Envista Holdings

Envista shares rose about 2.3% premarket after JPMorgan upgraded the stock from “Neutral” to “Overweight” and raised the price target from $29 to $32. The bank cited improved operational execution and a valuation that lags recent fundamentals, and expects to set a mid‑term growth target slightly above the previous 2–4% range at the investor day on Sept. 17. Envista had already reported Q2 results that beat expectations on adjusted EPS and revenue and subsequently raised its full‑year forecast. » More on de.investing.com

Envista Holdings named President and CEO Paul Keel effective immediately as chair of the board; Scott Huennekens remains lead independent director. The board approved a salary increase for Keel from $1.1 million to $1.3 million and a one-time equity award worth $10 million ($5 million RSUs, $5 million PSUs with a four-year vesting period). CFO Eric Hammes received PSUs worth $1.5 million with the same performance conditions. The actions are based on an SEC filing; Envista recently reported Q2 results and revenue above expectations and raised its full-year outlook. » More on de.investing.com

Envista reported Q2 sales of $731 million, driven by 5% core revenue growth, with adjusted EBITDA up 28% and adjusted EPS of $0.41 (up 58%). Free cash flow was $105 million and the company repurchased about 2.4 million shares. Equipment and consumables led segment growth while Specialty Products saw strength from Spark clear aligners and implant investments. Management raised 2026 guidance to 3.5–4.5% core sales growth, 11–14% adjusted EBITDA growth and adjusted EPS of $1.50–$1.55, but warned China volume-based procurement could pressure pricing in H2. » More on finance.yahoo.com

Envista Holdings reports Q1 revenue growth (+14.4% nominal; organic +9.5% before special items), adjusted EBITDA of $98.9 million (+25%) and adjusted earnings per share of $0.36. Operating cash flow and free cash flow were negative, driven by higher investments in plants in China and Finland. Management confirms the full-year outlook (organic growth 2–4%, adjusted EBITDA +7–13%) and launches a new $300 million repurchase program through the end of 2029. The stock is likely to trade sideways in the short term; the next price catalysts are expected from the quarterly results on August 5. » More on finanzen.net

Ariel Investments lists Envista Holdings as a top stock to buy following a strong first quarter marked by 9.5% core revenue growth, 25% adjusted EBITDA growth and 50% EPS growth. Barclays reiterated an Overweight rating but trimmed its price target to $32 from $34. Envista reiterated full-year guidance with sales growth of 2–4%, adjusted EBITDA growth of 7–13% and adjusted diluted EPS guidance of $1.35–$1.45. » More on finance.yahoo.com